Previous Article | Next Article ![]()
Journal of Virology, February 2008, p. 1350-1359, Vol. 82, No. 3
0022-538X/08/$08.00+0 doi:10.1128/JVI.01615-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

and
Sang-Moo Kang1*
Department of Microbiology and Immunology and Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia,1 Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama2
Received 24 July 2007/ Accepted 8 November 2007
Recovery from live influenza virus infection is known to induce heterosubtypic immunity. In contrast, immunity induced by inactivated vaccines is predominantly subtype specific. In this study, we investigated the heterosubtypic protective immunity induced by inactivated influenza virus. Intranasal immunization of mice with inactivated influenza virus A/PR8 (H1N1) provided complete protection against the homologous virus and a drift virus within the same subtype, A/WSN (H1N1), but not against the heterosubtypic virus A/Philippines (H3N2). However, coadministration of inactivated virus with cholera toxin as an adjuvant conferred complete heterosubtypic protection, without observed illness, even under conditions of CD4+ or CD8+ T-cell depletion. Analysis of immune correlates prior to challenge and postchallenge indicated that humoral immune responses with cross-neutralizing activity in lungs and in sera play a major role in conferring protective immunity against heterosubtypic challenge. This study has significant implications for developing broadly cross-reactive vaccines against newly emerging pathogenic influenza viruses.
Published ahead of print on 21 November 2007.
Present address: International Vaccine Institute, Seoul National University (SNU) Research Park, San 4-8, Bongcheon-7-dong, Kwanak-gu, Seoul 151-919, Korea.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»